Harbour Investments’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Harbour Investments's TXG Position: Q2 2026 in Review
Harbour Investments reduced its 10x Genomics (TXG) stake by 11% in Q2 2026, selling an estimated $917 and leaving 287 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3306.
Harbour Investments first reported a position in TXG in Q1 2021 and has held it in 21 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Harbour Investments held 287 shares of 10x Genomics worth $11K as of Q2 2026.
- Harbour Investments sold 35 10x Genomics shares in Q2 2026, an estimated $917.
- 10x Genomics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3306 holding.
- Harbour Investments first reported a position in 10x Genomics in Q1 2021 and has held it in 21 quarters since.
- 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.